BRAINTEASER app. collects the data on evolution of ALS and MS diseases, following the state-of-the-art approach based on standard questionnaires, physiological monitoring using wearable devices (Garmin devices), symptoms reporting and personalised support according to the type of disease and progress.
The app. is part of the EU-funded project BRAINTEASER (Horizon 2020 Programme Grant id 101017598), and it will also be used to validate the prognostic tools and risk assessment models created in the project.
More information can be found here: https://brainteaser.health